Cargando…

Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR

Non-invasive molecular analysis of circulating tumor DNA (ctDNA) is a promising application in personalized cancer management, although there is still much to learn about the biological characteristics of ctDNA. The present study compared absolute amounts of KRAS mutated ctDNA and total circulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kloten, Vera, Rüchel, Nadine, Brüchle, Nadina Ortiz, Gasthaus, Janina, Freudenmacher, Nils, Steib, Florian, Mijnes, Jolein, Eschenbruch, Julian, Binnebösel, Marcel, Knüchel, Ruth, Dahl, Edgar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689682/ https://www.ncbi.nlm.nih.gov/pubmed/29156792 http://dx.doi.org/10.18632/oncotarget.21134

Ejemplares similares

Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients’ Outcome in Basal-Like Breast Cancer
por: Kloten, Vera, et al.
Publicado: (2016)

Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection
por: Mijnes, Jolein, et al.
Publicado: (2020)

SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection
por: Mijnes, Jolein, et al.
Publicado: (2019)

Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer
por: Mijnes, Jolein, et al.
Publicado: (2018)

The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells
por: Rose, Michael, et al.
Publicado: (2021)

Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype
por: Rübben, Albert, et al.
Publicado: (2020)

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy
por: Schnitzler, Tician, et al.
Publicado: (2020)

SWI/SNF Alterations in Squamous Bladder Cancers
por: Achenbach, Fabian, et al.
Publicado: (2020)

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
por: Kloten, Vera, et al.
Publicado: (2013)

Molecular Characterization of Muellerian Tumors of the Urinary Tract
por: Ortiz-Brüchle, Nadina, et al.
Publicado: (2021)

Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer
por: Hauschulz, Maximilian, et al.
Publicado: (2023)

SARS‐CoV‐2 RNA screening in routine pathology specimens
por: von Stillfried, Saskia, et al.
Publicado: (2021)

Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
por: Baldelli, Elisa, et al.
Publicado: (2021)

Epigenetic inactivation of ST6GAL1 in human bladder cancer
por: Antony, Pia, et al.
Publicado: (2014)

The origins and genetic interactions of KRAS mutations are allele- and tissue-specific
por: Cook, Joshua H., et al.
Publicado: (2021)

Biological significance of KRAS mutant allele expression in ovarian endometriosis
por: Yachida, Nozomi, et al.
Publicado: (2021)

Enhancer of the rudimentary gene homologue (ERH) expression pattern in sporadic human breast cancer and normal breast tissue
por: Zafrakas, Menelaos, et al.
Publicado: (2008)

KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex
por: Rao, Donald D., et al.
Publicado: (2018)

Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy
por: Alves, Sara, et al.
Publicado: (2015)

MICA (∗)012:01 Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer
por: Ding, Weifeng, et al.
Publicado: (2020)

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021)

A Chamber-Based Digital PCR Based on a Microfluidic Chip for the Absolute Quantification and Analysis of KRAS Mutation
por: Ren, Jie, et al.
Publicado: (2023)

PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data
por: Greenman, Chris D., et al.
Publicado: (2010)

Perceiving pitch absolutely: Comparing absolute and relative pitch possessors in a pitch memory task
por: Schulze, Katrin, et al.
Publicado: (2009)

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
por: Veeck, Jürgen, et al.
Publicado: (2008)

Optimized Multiplex Detection of 7 KRAS Mutations by Taqman Allele-Specific qPCR
por: Orue, Andrea, et al.
Publicado: (2016)

Allele-Specific PCR for KRAS Mutation Detection Using Phosphoryl Guanidine Modified Primers
por: Chubarov, Alexey S., et al.
Publicado: (2020)

KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer
por: Suzuki, Tatsunori, et al.
Publicado: (2022)

Alisertib exerts KRAS allele‑specific anticancer effects on colorectal cancer cell lines
por: Ren, Baojun, et al.
Publicado: (2023)

KRAS analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice
por: Sundström, Magnus, et al.
Publicado: (2010)

Selective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells
por: Lee, Wookjae, et al.
Publicado: (2018)

ITIH5 mediates epigenetic reprogramming of breast cancer cells
por: Rose, Michael, et al.
Publicado: (2017)

Genetic polymorphisms in interleukin-1β (rs1143634) and interleukin-8 (rs4073) are associated with survival after resection of intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2023)

Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies
por: Zafrakas, Menelaos, et al.
Publicado: (2006)

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours
por: Veeck, Jürgen, et al.
Publicado: (2008)

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer
por: Wiesmann, Frank, et al.
Publicado: (2009)

The Microbiome in Childhood Acute Lymphoblastic Leukemia
por: Oldenburg, Marina, et al.
Publicado: (2021)

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
por: Puladi, Behrus, et al.
Publicado: (2021)

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab
por: Del Re, Marzia, et al.
Publicado: (2014)

KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients
por: Wang, Zhe-Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cilrets3k0dp68hgm2ol93j701